Abbott to Present at Goldman Sachs 32nd Annual Global Healthcare Conference

ABBOTT PARK, Ill., May 25, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Goldman Sachs 32nd Annual Global Healthcare Conference on Wednesday, June 8, 2011. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a presentation on the company at 11:20 a.m. Central time.

A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at www.abbottinvestor.com. An archived edition of the presentation will be available later that day.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs nearly 90,000 people and markets its products in more than 130 countries.

Abbott information is available on the company's Web site at www.abbott.com.

SOURCE Abbott

Suggested Articles

BMS’s Opdivo has plenty of competition in its current bladder cancer indication—so it’s hoping to strike out on its own in a new area of the disease.

The Japanese approval, under the brand name Jyseleca, came a month after an FDA complete response letter that asked Gilead for more data.

The Trump Administration has opened the doors for Florida and other states to import prescription drugs from Canada—despite industry objections.